Friday 23 August 2024

U.S. Medical Tourism Market by The Johns Hopkins Hospital; Mayo Clinic; Cleveland Clinic; Cedars-Sinai; Massachusetts General Hospital; UCSF Health

 The U.S. Medical Tourism Market size is anticipated to reach USD 18.21 billion by 2030 and is anticipated to expand at a CAGR of 13.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market has experienced significant growth in recent times, driven by the increasing presence of internationally accredited hospitals and the reputation for providing cutting-edge medical treatments.

The growing emphasis on personalized and patient-centric care in U.S. healthcare facilities is significantly driving the medical tourism industry in the country. Hospitals and clinics increasingly focus on tailored treatments to individual patient needs, providing personalized care plans, and enhancing the overall patient experience. This high-quality, patient-centered care is expected to witness high demand from international patients seeking an advanced and customized approach to their health.

Moreover, American patients are increasingly traveling to international destinations for various medical procedures, including elective surgeries, dental care, and cosmetic treatments. International medical providers are responding to this demand by offering comprehensive healthcare packages that include medical treatments, travel arrangements, accommodation, and concierge services. These all-inclusive packages simplify the patient process, making it easier to manage their medical journey and ensuring a smooth and supportive experience.

List of Key Players in the U.S. Medical Tourism Market

  • The Johns Hopkins Hospital
  • Mayo Clinic
  • Cleveland Clinic
  • Cedars-Sinai
  • Massachusetts General Hospital
  • UCSF Health
  • NewYork-Presbyterian Hospital
  • Brigham and Women's Hospital
  • Ronald Regan UCLA Medical Center
  • Northwestern Memorial Hospital

Related Press Release@ U.S. Medical Tourism Market Report

U.S. Medical Tourism Market Report Highlights

  • The inbound medical tourism segment dominated the market with a revenue share of 50.63% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The segment's growth is attributed to the presence of accredited hospitals and specialized centers ensuring high-quality, reliable healthcare that appeals to patients seeking top-tier medical services..
  • The outbound medical tourism segment is expected to witness significant growth over the forecast period. This is attributed to the rising healthcare costs in the U.S. & demand for affordable & accessible medical treatments with low waiting times.

U.S. Medical Tourism Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 8.74 billion

Revenue forecast in 2030

USD 18.21 billion

Growth rate

CAGR of 13.02% from 2024 to 2030

Actual data

2018 - 2023

Forecast period

2024 - 2030

 

U.S. Medical Tourism Market Segmentation

Grand View Research has segmented the U.S. medical tourism market based on type:

U.S. Medical Tourism Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Inbound Medical Tourism
  • Outbound Medical Tourism

Explore Horizon, the world's most expansive market research database

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com



No comments:

Post a Comment

Plasma Protease C1-inhibitor Market To Reach $6.21 Billion By 2030

  The global  Plasma Protease C1-Inhibitor Market  size is anticipated to reach USD 6.21 billion by 2030 , expanding at a CAGR of 9.79% from...